Related Experiment Video
Updated: May 10, 2026
05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Immune effector mechanisms implicated in atherosclerosis: from mice to humans
Peter Libby1, Andrew H Lichtman, Göran K Hansson
1Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB7, Boston, MA 02115, USA. plibby@rics.bwh.harvard.edu
Immunity
|July 2, 2013
Summary
Atherosclerosis, traditionally viewed as cholesterol buildup, is increasingly understood as an inflammatory disease involving the immune system. Understanding these immune mechanisms offers new strategies for preventing and treating cardiovascular disease.
Area of Science:
- Immunology
- Cardiovascular Science
- Pathogenesis of Atherosclerosis
Background:
- Atherosclerosis pathogenesis traditionally attributed to passive cholesterol deposition.
- Emerging evidence highlights the critical role of inflammation and immune responses in disease development.
- Innate and adaptive immunity are implicated in atherogenesis, linking risk factors to arterial dysfunction.
Purpose of the Study:
- To review current knowledge on atherosclerosis pathogenesis from an immunological perspective.
- To explore how host defense mechanisms contribute to this chronic cardiovascular disease.
- To identify new opportunities for mitigating atherosclerosis through immune-targeted strategies.
Main Methods:
- Review of experimental and clinical studies on atherosclerosis.
- Analysis of immunological pathways involved in atherogenesis.
- Examination of the link between immunity and cardiovascular disease.
Main Results:
- Immune effector mechanisms and inflammation are central to atherosclerosis development.
- Both innate and adaptive immunity play significant roles throughout atherogenesis.
- Traditional cardiovascular risk factors are linked to immune-mediated alterations in arterial function.
Conclusions:
- Atherosclerosis is an immune-mediated inflammatory disease, not merely passive cholesterol buildup.
- Understanding the immunological basis of atherosclerosis opens avenues for novel therapeutic and preventive strategies.
- Targeting inflammatory pathways presents a promising approach for cardiovascular disease mitigation.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:38Inflammation
Overview
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...